Association of aspirin and statin use with the risk of liver cancer in chronic hepatitis B: A nationwide population-based study.
Won-Mook ChoiHyo Jeong KimAe Jeong JoSo Hyun ChoiSeungbong HanMin Jung KoYoung Suk LimPublished in: Liver international : official journal of the International Association for the Study of the Liver (2021)
In this nationwide population-based study of patients with CHB, statin use was consistently associated with a significant and dose-dependent reduction in HCC risk. In contrast, the association between aspirin use and HCC risk reduction was not dose-dependent and was suggested to be confounded by statins.